What No One Told You About BRCA
I had the honor of speaking at #campbreastie this weekend, on stage, in workshops, on TV and most importantly, in conversation with so many incredible Breasties navigating life with a BRCA mutation. @thebreasties
Over and over, I heard the same questions. The same “Why didn’t anyone tell me that?” moments. So I put together this post for anyone who is BRCA+ (or loves someone who is), to share some of the less talked-about but deeply important things you deserve to know.
These lesser-discussed but very important considerations often get lost in the more commonly emphasized talking points like mastectomy or oophorectomy.
Swipe through for insights that might not have come up in your appointments. 🧬💬
Thank you to all the Breasties who asked me questions this weekend and who shared your stories with me. And a special shout out to Sara Rhode for being the GC camper and colleague who is also so passionate and knowledgeable about this and who helped answer questions all weekend too.
#brca #brca1 #brca2 #previvor #brca1positive #brca2positive #brcagene #breasties
While BRCA mutations are widely known for increasing the risk of breast and ovarian cancers, there are many other critical aspects to consider that often go unmentioned during medical consultations. For example, men carrying BRCA mutations face increased risks of male breast cancer, aggressive prostate cancer, pancreatic cancer, and melanoma, underscoring the importance of inclusive screening strategies for all genders. Family planning is another significant concern for BRCA+ individuals. If both partners carry the BRCA1 or BRCA2 mutation, there is a possibility of passing on two copies to their child, which can lead to serious conditions like Fanconi anemia. Advances such as IVF combined with Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) offer options to significantly reduce the risk of transmission, enabling families to make informed reproductive decisions. Screening recommendations are evolving beyond breast and ovarian cancer. New NCCN guidelines advise pancreatic cancer screening for BRCA2 carriers starting at age 50, or earlier based on family history, and also for some BRCA1 carriers. Additionally, given the increased melanoma risk, annual full-body skin checks and dilated eye exams, along with sun protection practices, are highly suggested even though official guidelines are still developing. Managing the psychological impact of living with a BRCA mutation is equally important. Many experience long-term anxiety, decision fatigue, and body image challenges especially post-surgery. Ongoing support from mental health professionals and genetic counselors can provide vital assistance throughout this journey. Regarding preventive surgery, recent approaches focus on risk-reducing salpingectomy with delayed oophorectomy, which involves removal of the fallopian tubes first to lower ovarian cancer risk while postponing menopause onset. However, removal of fallopian tubes affects natural pregnancy, so discussions with healthcare providers are necessary to explore appropriate timing and fertility options. Understanding these multifaceted factors provides a more comprehensive perspective on living with BRCA mutations. Continuing education, personalized medical guidance, and community support empower individuals and families to navigate risks and decisions with greater confidence and clarity.
